|
|
|
Rapamycin with GMP AND DMF |
is a Star Product of
|
 |
|
|
|
| General information |
| Registration name: Rapamycin with GMP AND DMF |
Other product names:
Rapamycin (Sirolimus)
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methyleth
Rapamicin
Sirolimus
rapamycin from streptomyces*hygroscopicus
Rapamycin
|
| CAS number 53123-88-9 |
|
| EINECS: |
| Formula: C51H79NO13 |
|
|
| Detailed information on the Star Product |
|
Rapamycin inhibited the proliferation of primary bone marrow cells induced by IL-3, GM-CSF, KL, or a complex mixture of factors present in cell-conditioned media. Rapamycin also inhibited the multiplication of colony-forming cells in suspension cultures containing IL-3 plus interleukin-1 (IL-1) or interleukin-11 (IL-11) plus KL. |
|
>> Ask for an offer
|
|
|
|
|
|
|
